NCT03640754View on ClinicalTrials.gov

A Study of the Safety and Effect of Repeated Administration of G-CSF on Hot Flashes in Postmenopausal Women

PHASE1CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

August 6, 2018

Primary Completion Date

January 21, 2022

Study Completion Date

February 22, 2022

Conditions
Postmenopausal Symptoms
Interventions
BIOLOGICAL

G-CSF

G-CSF injected subcutaneously 3 times (Days 0, 28, 56)

OTHER

Placebo/Saline

Placebo/saline injected subcutaneously 3 times (Days 0, 28, 56)

Trial Locations (2)

80045

Site 2, Aurora

80209

Site 1, Denver

Sponsors

Lead Sponsor

MenoGeniX, Inc.
All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute on Aging (NIA)

NIH

lead

MenoGeniX, Inc.

INDUSTRY

NCT03640754 - A Study of the Safety and Effect of Repeated Administration of G-CSF on Hot Flashes in Postmenopausal Women | Biotech Hunter | Biotech Hunter